BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: El-demerdash E, Abdel-sattar SA, El-bakly WM, Mohamed EA. Antifibrotic Effects of Carvedilol and Impact of Liver Fibrosis on Carvedilol Pharmacokinetics in a Rat model. Eur J Drug Metab Pharmacokinet 2017;42:767-79. [DOI: 10.1007/s13318-016-0391-9] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 1.7] [Reference Citation Analysis]
Number Citing Articles
1 Mohamed DI, Ezzat SF, Elayat WM, El-kharashi OA, El-kareem HFA, Nahas HHA, Abdel-wahab BA, Alshawwa SZ, Saleh A, Helmy YA, Khairy E, Saied EM. Hepatoprotective Role of Carvedilol against Ischemic Hepatitis Associated with Acute Heart Failure via Targeting miRNA-17 and Mitochondrial Dynamics-Related Proteins: An In Vivo and In Silico Study. Pharmaceuticals 2022;15:832. [DOI: 10.3390/ph15070832] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 4.0] [Reference Citation Analysis]
2 Abdullah AS, Sayed IETE, El-Torgoman AMA, Kalam A, Wageh S, Kamel MA. Green Synthesis of Silymarin-Chitosan Nanoparticles as a New Nano Formulation with Enhanced Anti-Fibrotic Effects against Liver Fibrosis. Int J Mol Sci 2022;23:5420. [PMID: 35628233 DOI: 10.3390/ijms23105420] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
3 Medina-pizaño MY, Medina-rosales MN, Martínez-hernández SL, Aldaba-muruato LR, Macías-pérez JR, Sánchez-alemán E, Ventura-juárez J, Muñoz-ortega MH, Borrás C. Protective Effect of Curcumin against Doxazosin- and Carvedilol-Induced Oxidative Stress in HepG2 Cells. Oxidative Medicine and Cellular Longevity 2022;2022:1-15. [DOI: 10.1155/2022/6085515] [Reference Citation Analysis]
4 Baghaei K, Mazhari S, Tokhanbigli S, Parsamanesh G, Alavifard H, Schaafsma D, Ghavami S. Therapeutic potential of targeting regulatory mechanisms of hepatic stellate cell activation in liver fibrosis. Drug Discov Today 2021:S1359-6446(21)00562-6. [PMID: 34952225 DOI: 10.1016/j.drudis.2021.12.012] [Reference Citation Analysis]
5 El Sayed NF, Abdallah DM, Awad AS, Ahmed KA, El-Abhar HS. Novel peripheral role of Nurr-1/GDNF/AKT trajectory in carvedilol and/or morin hydrate hepatoprotective effect in a model of hepatic ischemia/reperfusion. Life Sci 2021;273:119235. [PMID: 33607152 DOI: 10.1016/j.lfs.2021.119235] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
6 Wei F, Guo L, Xu Y, Chen D, Gong M. Comparative Pharmacokinetic Study of Taxifolin after Oral Administration of Fructus Polygoni Orientalis Extract in Normal and Fibrotic Rats by UPLC-MS/MS. Evid Based Complement Alternat Med 2019;2019:9348075. [PMID: 31976002 DOI: 10.1155/2019/9348075] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
7 Ling L, Li G, Wang G, Meng D, Li Z, Zhang C. Carvedilol improves liver cirrhosis in rats by inhibiting hepatic stellate cell activation, proliferation, invasion and collagen synthesis. Mol Med Rep 2019;20:1605-12. [PMID: 31257490 DOI: 10.3892/mmr.2019.10401] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
8 Helal MG, Said E. Carvedilol attenuates experimentally induced silicosis in rats via modulation of P-AKT/mTOR/TGFβ1 signaling. International Immunopharmacology 2019;70:47-55. [DOI: 10.1016/j.intimp.2019.02.011] [Cited by in Crossref: 7] [Cited by in F6Publishing: 12] [Article Influence: 2.3] [Reference Citation Analysis]
9 Parker BM, Rogers SL, Lymperopoulos A. Clinical pharmacogenomics of carvedilol: the stereo-selective metabolism angle. Pharmacogenomics 2018;19:1089-93. [DOI: 10.2217/pgs-2018-0115] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 1.3] [Reference Citation Analysis]